Skip to content
Search

Latest Stories

Over 50% of pharmacists with disabilities face workplace discrimination

Over 50% of pharmacists with disabilities face workplace discrimination

‘Employers should create an environment where pharmacists with disabilitiescan work safely and without fear of discrimination’

The Pharmacists' Defence Association Ability Network or PDA Ability Network has released initial findings from its disability discrimination survey, indicating the need for significant efforts to make workplaces more inclusive for pharmacists with disabilities.

Launched in February this year, the survey aims to establish the extent of discrimination faced in the workplace by pharmacists who are disabled or live with a long-term health condition.


Respondents reported encountering disability discrimination in a variety of ways, from employment being withdrawn upon discovery of their disability to employers declining to offer reasonable adjustments.

The initial survey report revealed that 40 per cent of participants expressed feeling excluded from the workforce, underemployed, or unemployed because of their disability.

It was found that nearly 70 per cent of participants either did not receive reasonable adjustments or only received partial reasonable adjustments to accommodate their disability.

More than half of respondents (53 per cent) reported experiencing discrimination in the workplace.

Among those who faced discrimination, 60 per cent said it came from their manager, while 40 per cent reported experiencing discrimination from colleagues.

Liz Larkin, PDA organiser and co-ordinator for the PDA Ability Network, said “Pharmacists are a talented skilled workforce but a proportion of pharmacists who have disabilities or long-term health conditions are discriminated against and excluded from the workforce.

“This is a terrible loss of skills and talent and we need employers to create an environment where disabled members can work safely and without fear of discrimination.”

The network said that it will use this evidence to inform its next campaign to lobby employers to meet their obligations under the Equality Act 2010 to provide reasonable adjustments.

“With one in five people in the UK being disabled, discrimination not only causes real distress, it means that a valued group of the workforce may find themselves not working should their employer not support them,” the network noted.

PDA members are encouraged to complete the online survey by Tuesday 30 April 2024.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less